SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-359961
Filing Date
2021-12-17
Accepted
2021-12-17 07:30:54
Documents
14
Period of Report
2021-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d256659d8k.htm   iXBRL 8-K 25659
2 EX-99.1 d256659dex991.htm EX-99.1 4179
6 GRAPHIC g256659dsp004.jpg GRAPHIC 2976
  Complete submission text file 0001193125-21-359961.txt   165384

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20211216.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20211216_lab.xml EX-101.LAB 19657
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20211216_pre.xml EX-101.PRE 12313
7 EXTRACTED XBRL INSTANCE DOCUMENT d256659d8k_htm.xml XML 3591
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 211499495
SIC: 2836 Biological Products, (No Diagnostic Substances)